Insider Trading & Ownership - SCHEIBLER LUKAS

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SCHEIBLER LUKAS
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2023-12-01
Sale		2023-12-05
7:40 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		10,000$60$600,000107,690
(Direct)		View
2023-09-06
Sale		2023-09-07
4:08 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		1,756$43.01$75,52668,299
(Direct)		View
2022-05-27
Sale		2022-05-31
4:30 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		10,000$43$430,00042,233
(Direct)		View
2022-04-05
Sale		2022-04-06
4:10 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		609$60.09$36,593101,624
(Direct)		View
2022-04-04
Sale		2022-04-05
4:08 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		3,504$56.96$199,589102,233
(Direct)		View
2022-04-01
Sale		2022-04-04
5:03 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		11,496$55.05$632,855105,737
(Direct)		View
2022-02-11
Sale		2022-02-14
6:20 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		1,666$46.8$77,96951,513
(Direct)		View
2022-02-10
Sale		2022-02-14
4:15 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		10,000$50$500,000118,179
(Direct)		View
2022-02-08
Sale		2022-02-10
08:32 am		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		10,000$45$450,000128,857
(Direct)		View
2022-01-31
Sale		2022-02-01
5:58 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		1,233$38.47$47,43453,857
(Direct)		View
2021-06-10
Sale		2021-06-11
4:07 pm		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		3,417$60$205,02026,651
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-12-01
Exercise		2023-12-05
7:40 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		10,000$13.85107,690
(Direct)		View
2023-12-01
Exercise		2023-12-05
7:40 pm		N/A
2029-02-07		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		10,000$0107,690
(Direct)		View
2023-02-21
Tax Withholding		2023-02-22
06:49 am		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		715$58.583,666
(Direct)		View
2023-02-21
Option Award		2023-02-22
06:49 am		N/A
2032-01-20		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		23,909$083,666
(Direct)		View
2023-02-10
Tax Withholding		2023-02-14
4:44 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		678$51.2160,472
(Direct)		View
2023-01-27
Tax Withholding		2023-01-30
5:03 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		542$52.7761,150
(Direct)		View
2023-01-20
Tax Withholding		2023-01-24
5:22 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		2,015$52.0561,692
(Direct)		View
2023-01-12
Option Award		2023-01-17
7:42 pm		N/A
2033-01-11		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		35,472$52.6699,179
(Direct)		View
2023-01-12
Option Award		2023-01-17
7:42 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer		22,580$099,179
(Direct)		View
2022-04-21
Other		2022-05-31
4:30 pm		N/A
2031-01-27		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		13,125$042,233
(Direct)		View
2022-04-05
Exercise		2022-04-06
4:10 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		609$13.85101,624
(Direct)		View
2022-04-05
Exercise		2022-04-06
4:10 pm		N/A
2029-02-07		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		609$0101,624
(Direct)		View
2022-04-04
Exercise		2022-04-05
4:08 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		3,504$13.85102,233
(Direct)		View
2022-04-04
Exercise		2022-04-05
4:08 pm		N/A
2029-02-07		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		3,504$0102,233
(Direct)		View
2022-04-01
Exercise		2022-04-04
5:03 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		11,496$13.85105,737
(Direct)		View
2022-04-01
Exercise		2022-04-04
5:03 pm		N/A
2029-02-07		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		11,496$0105,737
(Direct)		View
2022-02-14
Exercise		2022-02-15
4:58 pm		N/A
2028-04-12		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		720$0186,010
(Direct)		View
2022-02-14
Exercise		2022-02-15
4:58 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		720$26.73186,010
(Direct)		View
2022-02-10
Exercise		2022-02-14
4:15 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		10,000$13.85118,179
(Direct)		View
2022-02-10
Exercise		2022-02-14
4:15 pm		N/A
2029-02-07		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		10,000$0118,179
(Direct)		View
2022-02-10
Tax Withholding		2022-02-14
4:15 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		678$47.12118,179
(Direct)		View
2022-02-08
Exercise		2022-02-10
08:32 am		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		10,000$13.85128,857
(Direct)		View
2022-02-08
Exercise		2022-02-10
08:32 am		N/A
2029-02-07		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		10,000$0128,857
(Direct)		View
2022-01-28
Tax Withholding		2022-02-01
5:58 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		642$38.5953,857
(Direct)		View
2022-01-21
Option Award		2022-01-25
4:58 pm		N/A
2032-01-20		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		63,002$092,683
(Direct)		View
2022-01-21
Exercise		2022-01-24
5:26 pm		N/A
2028-04-12		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		3,021$0164,178
(Direct)		View
2022-01-21
Exercise		2022-01-24
5:26 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		3,021$26.73164,178
(Direct)		View
2021-02-10
Tax Withholding		2021-02-11
4:18 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		680$47.7229,290
(Direct)		View
2021-01-28
Option Award		2021-02-01
4:39 pm		N/A
2031-01-27		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		65,625$086,220
(Direct)		View
2020-12-08
Exercise		2020-12-09
5:34 pm		N/A
2028-04-12		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		7,482$0158,113
(Direct)		View
2020-12-08
Exercise		2020-12-09
5:34 pm		N/A
N/A		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER		7,482$26.73158,113
(Direct)		View
2020-02-10
Option Award		2020-02-12
5:13 pm		N/A
2030-02-09		Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
See Remarks		65,625$068,560
(Direct)		View